藥明巨諾-B：2023年度報告

Futu NewsApr 26 06:21 · Announcements

Big benefits have arrived! Pharmacovigilance is getting stronger. What's the situation?

Yao Ming Kangde's deep participation in the US healthcare field has far surpassed congressional discussions. Some senior members of the country's biotech industry have clearly opposed the bill.

券商中國Apr 17 16:06

Pharmaceutical Junuo (02126.HK): Significant results in cost reduction and efficiency explore clinical applications of self-exemption

The 2023 results are in line with our expectations. The company announced the 2023 results: revenue of 174 million yuan, up 19.3% year on year; net profit to mother - 768 million yuan. The 2023 results are in line with our expectations. Development trend Benuo

中金公司Mar 22 18:51

JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023

JW (Cayman) Therapeutics (HKG:2126) recorded a narrower attributable loss for the year ended Dec. 31, 2023, of 768 million yuan from 846.1 million yuan during the year-ago period, a Tuesday filing on

MT NewswiresMar 20 20:44

Pharmaceutical Juno-B (02126) released annual results, gross profit of 882.19 million yuan, a year-on-year increase of 50.14%

Pharmaceutical Juno-B (02126) announced its annual results for the year ended December 31, 2023. The group...

Zhitong FinanceMar 20 16:44

JW THERAP-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND CHANGE IN USE OF NET PROCEEDS FROM LISTING

Futu NewsMar 20 16:34 · Announcements